Patients with Lower Positive Lymph Nodes Ratio May Benefit from Preoperative Radiotherapy in Stage III Non-Small Cell Lung Cancer

BACKGROUND: Although preoperative radiotherapy (PORT) is a promising therapeutic option for stage III non-small cell lung cancer (NSCLC), the efficacy of this treatment remains controversial. The positive lymph node ratio (PLNR) is recognized as an independent prognostic factor for survival. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ruiyang, Shang, Shijie, Huang, Xinyi, Nie, Yu, Wang, Fei, Yu, Jinming, Chen, Dawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185974/
https://www.ncbi.nlm.nih.gov/pubmed/37157831
http://dx.doi.org/10.1177/15330338231173498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185974/
https://www.ncbi.nlm.nih.gov/pubmed/37157831
http://dx.doi.org/10.1177/15330338231173498

Ejemplares similares